…reached for evaluation of follow-up results. Thirty-three patients were free of pain, 21 had marked improvement, 18 had some improvement, and 37 experienced no change. Therefore, a good response immediately…
SEARCH
Search Results
Xstrahl in Action: SARRP used in evaluation of four different small animal radiation plans on tumour and normal tissue dosimetry
…to studied the impact of four different radiotherapy plans on tumour and normal tissue dosimetry. Plans were created using four different approaches (single beam, parallel opposed pair, single plane arcs,…
Minimum Reporting Standards for Preclinical Radiobiology Irradiators and Dosimetry
…report the recommended irradiation parameters, and is offered as an aid to help authors report consist*]}*ent, reproducible, and accurate irradiation conditions. This table may be useful to document experimental conditions…
Xstrahl in Action: Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival
…and retention in tissue with a higher brain to plasma ratio in the IV treatment group as compared to the treatment with IP preparation. The findings suggest that the IV…
kV Radiotherapy Treatment in Locally Advanced or Metastatic Breast Cancer
Researchers sought to understand the role of kV treatment in locally advanced and/or metastatic breast cancer in which kV radiotherapy was used as the primary modality or as supportive treatment…
Xstrahl in Action: Radiosensitization In Vivo by Histone Deacetylase Inhibition
As the population ages, more elderly patients require radiotherapy-based treatment for their pelvic malignancies, including muscle-invasive bladder cancer, as they are unfit for major surgery. Therefore, there is an urgent…
Dose-dependent changes in cardiac function, strain and remodelling in a pre-clinical model of heart base irradiation
…group. d) Heart Volume receiving at least 5 Gy and e) Mean Heart dose for all treatment groups. Data presented for 7 mice per treatment group ± standard error of…
Validating clinical practice using SARRP; simulating clinical radiotherapy in a model mimicking spontaneous occurring NSCLC
…Engineered Mouse Model of Lung Cancer. IJROPB. 2016 Over 60% of cancer patients worldwide will receive radiotherapy as a part of their overall treatment plan. Recently, stereotactic body radiation therapy…
Xstrahl in Action: Localized microbubble therapy for improving treatment response to radiotherapy
…alone, there was a 170% reduction in tumor growth 7 days post treatment and a 3.2X improvement in median survival time when radiotherapy was combined with UTMD. These results indicate…
Xstrahl in action: MRI-Guided Radiotherapy with SARRP
…tomography (PET). These technologies enable increased accuracy of tumor identification, measurement, and treatment. Recently, a group of investigators from Columbia University lead by Dr. Simon K. Cheng have developed an…